ArQule Inc
AstraZeneca Plc
Bayer AG
Laekna Therapeutics Shanghai Co Ltd
Merck & Co Inc
Merck KGaA
Novartis AG
Rexahn Pharmaceuticals Inc
Published | Pages | Publisher | Report code |
---|---|---|---|
Jan 2020 | 83 | Global Markets Direct | ASDR-506329 |
ArQule Inc
AstraZeneca Plc
Bayer AG
Laekna Therapeutics Shanghai Co Ltd
Merck & Co Inc
Merck KGaA
Novartis AG
Rexahn Pharmaceuticals Inc